Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Targeting EZH2 to Stop Triple-Negative Breast Cancer Spread
Research & Development Targeting EZH2 to Stop Triple-Negative Breast Cancer Spread

Triple-negative breast cancer (TNBC) remains one of the most formidable challenges in oncology, characterized by its aggressive nature and lack of the three common receptors—estrogen, progesterone, and HER2—that many standard therapies target, leaving patients with limited treatment options and

How Does DeepMice Revolutionize Drug Discovery with AI?
Research & Development How Does DeepMice Revolutionize Drug Discovery with AI?

In the intricate and often arduous world of drug discovery, where the journey from concept to cure can span over a decade and cost billions, a transformative tool has emerged to redefine the landscape. DeepMice, an innovative protein-ligand molecular docking model recently highlighted in Molecular

How Is AI Revolutionizing Antibiotic Development for IBD?
Tech & Innovation How Is AI Revolutionizing Antibiotic Development for IBD?

Imagine a world where millions suffering from inflammatory bowel diseases (IBD) like Crohn’s disease face not only chronic pain and discomfort but also the growing threat of drug-resistant bacteria in their gut, driving an urgent need for innovative treatments. These treatments must target harmful

Fast-Tracking Advanced Therapies with Regulatory Success
Management & Regulatory Fast-Tracking Advanced Therapies with Regulatory Success

In the rapidly evolving realm of advanced therapy medicinal products (ATMPs) and complex biologics, the promise of transforming patient care is both exhilarating and daunting, as these cutting-edge treatments hold the potential to address some of the most pressing unmet medical needs, from rare

How Do Antimicrobial Peptides Kill Bacterial Cells?
Research & Development How Do Antimicrobial Peptides Kill Bacterial Cells?

What if a microscopic weapon, hidden within the human body, could be the key to defeating one of the deadliest health threats of modern times—antibiotic-resistant bacteria, which claim millions of lives each year due to infections that no longer respond to traditional treatments? This urgent crisis

Can Fungi Revolutionize Biomedical Engineering with Hydrogels?
Biotech & Bioprocessing Can Fungi Revolutionize Biomedical Engineering with Hydrogels?

Imagine a world where a common soil mold could redefine the future of medical technology, offering solutions for tissue regeneration and flexible medical devices that seamlessly integrate with the human body. A groundbreaking discovery from researchers at a leading university has unveiled the

Does Poor Sleep Accelerate Brain Aging? New Study Reveals All
Tech & Innovation Does Poor Sleep Accelerate Brain Aging? New Study Reveals All

What if the key to maintaining a sharp, youthful mind isn’t found in the latest brain-boosting app or expensive supplement, but in something as basic as closing your eyes for a solid night’s rest? A staggering number of adults—nearly one in three—report struggling with sleep, and a groundbreaking

Political Gridlock Puts Telehealth at Risk in Shutdown Crisis
Tech & Innovation Political Gridlock Puts Telehealth at Risk in Shutdown Crisis

As the United States Congress stands on the precipice of a federal government shutdown, a fierce partisan divide over funding is threatening to upend critical services, with healthcare at the forefront of concern, especially as the critical deadline approaches at midnight on September 30. The

AI-Driven Optogenetics for Parkinson’s – Review
Tech & Innovation AI-Driven Optogenetics for Parkinson’s – Review

Imagine a world where Parkinson’s disease, a condition affecting millions globally with its debilitating motor symptoms, can be detected before the first tremor and treated with pinpoint accuracy. This neurodegenerative disorder, characterized by the loss of dopamine-producing neurons, has long

Can mRNA Vaccines Revolutionize AMD Treatment?
Research & Development Can mRNA Vaccines Revolutionize AMD Treatment?

Imagine a world where a single injection in the arm could halt the progression of a debilitating eye condition like age-related macular degeneration (AMD), a disease that affects nearly 200 million people globally and stands as a leading cause of vision loss among those over 60. This vision is

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later